The Osceola School District Board Workshop held on July 15, 2025, focused on innovative strategies to manage healthcare costs for employees. A key discussion centered around encouraging staff to utilize international pharmacy options for prescription medications, specifically mentioning a significant cost difference.

Board members proposed waiving co-pays for employees who choose to use Elect Rx International, which could allow them to access medications at no cost. In contrast, obtaining the same medications domestically would incur a monthly expense of $150. This initiative aims to align member outcomes with the overall goals of the health plan, potentially leading to substantial savings for both employees and the district.

Additionally, the board discussed the future transition of certain medications, such as Humira, to domestic sources once biosimilars become available. This shift is expected to further optimize healthcare spending while ensuring that employees have access to necessary treatments.

The meeting underscored the district's commitment to exploring cost-effective healthcare solutions that benefit both employees and the organization as a whole. Further steps will be taken to implement these strategies and monitor their effectiveness in the coming months.